9 Meters Biopharma IncChange company Symbol lookupSelect an option...NMTR 9 Meters Biopharma IncBOXD Boxed IncALLR Allarity Therapeutics IncSIVB SVB Financial GroupLYLT Loyalty Ventures IncNMRD Nemaura Medical IncLOGI Logitech International SABIOC Biocept IncKT KT CorpSVRA Savara IncGo
9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for people with rare digestive diseases, gastrointestinal (GI) conditions with unmet needs. Its pipeline includes Vurolenatide, Larazotide, NM-102, NM-003, NM-136 and NM-004. Vurolenatide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that combines exenatide with an extended half-life technology for treatment of short bowel syndrome (SBS). Larazotide is an 8-amino acid peptide formulated into an orally administered capsule for treatment of celiac disease. NM-102 is a small molecule peptide, is being developed as a potential microbiome modulator and is undergoing an indication selection process. NM-003 is a long-acting GLP-2 receptor agonist, for prevention of acute graft versus host disease. NM-004 is a double-cleaved mesalamine with an immunomodulator for pediatric ulcerative colitis.
|
|
|
|
| |
Upcoming Events
- MAR
21
2023 - Q4 2022 Earnings Release
- EPS estimate consensus
-$0.792 - Estimate range
-$1.00 to -$0.653 - Previous year's Q4 actual
-$0.80
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| November 8, 2022 | Q3 2022 Earnings Release | -$0.72 | -$0.87 to -$0.80 | -$1.00 |
| August 15, 2022 | Q2 2022 Earnings Release | -$0.80 | -$0.05 to -$0.04 | -$0.60 |
| May 16, 2022 | Q1 2022 Earnings Release | -$0.80 | -$0.04 to -$0.03 | -$0.60 |
| March 23, 2022 | Q4 2021 Earnings Release | -$0.80 | -$0.04 to -$0.03 | -- |
Past Stock Splits
| Date | Event description | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| October 18, 2022 | 1:20 Stock Split | |||||||||
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.